Lorena Donnici
Overview
Explore the profile of Lorena Donnici including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santambrogio C, Toccafondi M, Donnici L, Pesce E, De Francesco R, Grifantini R, et al.
Chembiochem
. 2025 Feb;
:e202500106.
PMID: 39982661
Recognition of glycans by simple synthetic receptors is a key issue in supramolecular chemistry, endowed with relevant implications in glycobiology and medicine. In this context, glycoproteins featuring N-glycans represent an...
2.
Fumagalli V, Rava M, Marotta D, Di Lucia P, Bono E, Giustini L, et al.
Nat Immunol
. 2024 Mar;
25(4):633-643.
PMID: 38486021
Vaccines have reduced severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) morbidity and mortality, yet emerging variants challenge their effectiveness. The prevailing approach to updating vaccines targets the antibody response, operating...
3.
Galeota E, Bevilacqua V, Gobbini A, Gruarin P, Bombaci M, Pesce E, et al.
Clin Immunol
. 2024 Feb;
261:110164.
PMID: 38417765
Multiple vaccines have been approved to control COVID-19 pandemic, with Pfizer/BioNTech (BNT162b2) being widely used. We conducted a longitudinal analysis of the immune response elicited after three doses of the...
4.
DAcunto E, Muzi A, Marchese S, Donnici L, Chiarini V, Bucci F, et al.
Antibodies (Basel)
. 2024 Jan;
13(1).
PMID: 38247569
The COVID-19 pandemic, once a global crisis, is now largely under control, a testament to the extraordinary global efforts involving vaccination and public health measures. However, the relentless evolution of...
5.
Unali G, Crivicich G, Pagani I, Abou-Alezz M, Folchini F, Valeri E, et al.
EMBO J
. 2023 Mar;
42(10):e112234.
PMID: 36970857
The interferon-induced transmembrane proteins (IFITM) are implicated in several biological processes, including antiviral defense, but their modes of action remain debated. Here, taking advantage of pseudotyped viral entry assays and...
6.
Fumagalli V, Di Lucia P, Rava M, Marotta D, Bono E, Grassi S, et al.
EMBO Mol Med
. 2023 Mar;
15(5):e17580.
PMID: 36946379
Alongside vaccines, antiviral drugs are becoming an integral part of our response to the SARS-CoV-2 pandemic. Nirmatrelvir-an orally available inhibitor of the 3-chymotrypsin-like cysteine protease-has been shown to reduce the...
7.
Andreano E, Paciello I, Pierleoni G, Piccini G, Abbiento V, Antonelli G, et al.
Nat Commun
. 2023 Jan;
14(1):53.
PMID: 36599850
The continuous evolution of SARS-CoV-2 generated highly mutated variants able to escape natural and vaccine-induced primary immunity. The administration of a third mRNA vaccine dose induces a secondary response with...
8.
Miluzio A, Cuomo A, Cordiglieri C, Donnici L, Pesce E, Bombaci M, et al.
EBioMedicine
. 2022 Dec;
87:104390.
PMID: 36584595
Background: The COVID-19 pandemic is an infectious disease caused by SARS-CoV-2. The first step of SARS-CoV-2 infection is the recognition of angiotensin-converting enzyme 2 (ACE2) receptors by the receptor-binding domain...
9.
Ivanova Bencheva L, Donnici L, Ferrante L, Prandi A, Sinisi R, De Matteo M, et al.
Bioorg Med Chem Lett
. 2022 Jul;
73:128904.
PMID: 35868496
Chronic hepatitis B (CHB) is a major worldwide public health problem and novel anti-HBV therapies preventing liver disease progression to cirrhosis and hepatocellular carcinoma are urgently needed. Over the last...
10.
Favalli A, Favalli E, Gobbini A, Zagato E, Bombaci M, Maioli G, et al.
Front Immunol
. 2022 Jun;
13:873195.
PMID: 35757699
COVID-19 has proven to be particularly serious and life-threatening for patients presenting with pre-existing pathologies. Patients affected by rheumatic musculoskeletal disease (RMD) are likely to have impaired immune responses against...